$256.46

-1.44%

ABBV

AbbVie Inc.

•Healthcare

Immunology Leader

Dividend Payer

Healthcare Mega-Cap

Patent Moat

Immunology Leader

Dividend Payer

Healthcare Mega-Cap

Patent Moat

Loading Chart...

FIT ANALYSIS

Required for personalization

FIT ANALYSIS

Checking Membership...

STOCK DNA

Valuation

6/10

Quality

4/10

Growth

4/10

Strength

2/10

Dividend

4/10

Similar Stocks

LLY Eli Lilly and Company

JNJ Johnson & Johnson

BIIB Biogen Inc.

BMY Bristol-Myers Squibb Company

TAK Takeda Pharmaceutical Company L

Health Indicators

Price Trend

Upwards

Momentum

Neutral

Balance Sheet

Distressed (Neg. Equity)

Earnings

Growth

Dividend Yield

2.66%

Market Cap

$453.19B

TALK TO YOUR STOCK

EQUITAI ASSISTANT

AbbVie is a global pharmaceutical company that develops advanced medicines targeting complex diseases in immunology, oncology, and neuroscience. It also owns the popular aesthetics brand Botox, providing a steady stream of highly profitable, consumer-driven revenue. I have synthesized my analysis of its core fundamentals, live market action, and peer metrics to provide a comprehensive thesis. What specific areas can I detail for you?

AI can make mistakes. Verify important information.

Talk to Your Stock•open live chat

Pro EquitAI Research

Retrieving premium status...